Best for Insurance-navigation support and ongoing check-ins
Found
6.6/10Found stands out here for insurance-navigation support and ongoing check-ins, based on dated commercial evidence—not medical outcomes or individual suitability.3
A source-bound comparison of visible offer detail, product-status language, clinician process, price, and unresolved intake-shell fields.
Affiliate disclosure: We may earn a commission if you sign up through links below — this doesn't affect our rankings.
Serena Health and Oak Longevity were accepted into the 13-program comparison pool without a dedicated head-to-head route. Their public evidence depth differs: Serena Health’s archived page published formulation, price, review, and shipping language, while Oak’s captured public destination was an intake shell with no product or compounding facts.
Found Health and Gala Health appear only as source-disclosure benchmarks. This page does not infer that more copy means better care, and it does not rank outcomes. It asks whether a reader can identify the offer, product category, clinician process, price exposure, and fulfillment path before beginning intake.
Audit the intake shell before entering sensitive answers. Look for the legal operator, privacy notice, consent sequence, telehealth modality, applicable-state disclosure, prepayment timing, exit path, account deletion route, product-form statement, and post-questionnaire decision owner. Oak’s public shell did not expose enough of that sequence for a commercial verdict. Serena’s deeper offer page still leaves regulatory and renewal questions that visible detail alone cannot settle.


Quick answer · Serena Health
Serena Health published more commercial and process detail than Oak’s captured intake shell, while medication approval status and renewal terms still require confirmation.1
5.9/10Choose by intent
Jump to the scored card, verify the cited terms, or use the private matching path. A commercial fit is not a treatment recommendation.
Best for Insurance-navigation support and ongoing check-ins
Found stands out here for insurance-navigation support and ongoing check-ins, based on dated commercial evidence—not medical outcomes or individual suitability.3

Best for Visible review and shipping expectations with explicit product-status uncertainty
Serena Health stands out here for visible review and shipping expectations with explicit product-status uncertainty, based on dated commercial evidence—not medical outcomes or individual suitability.1

Best for A stated flat monthly figure across dose levels on a yearly plan
Gala GLP-1 stands out here for a stated flat monthly figure across dose levels on a yearly plan, based on dated commercial evidence—not medical outcomes or individual suitability.4
At-a-glance comparison
Sort by the weighted score or published starting price. Every score remains tied to the five criteria below.
| Logo | Provider | Starting price | Medications offered | Insurance | Average wait | Clinic Scout score | Public review signal | Offer / promo | Next steps |
|---|---|---|---|---|---|---|---|---|---|
| Foundaffiliate relationship · commission may apply | Compounded options advertised from $99/month; membership and medication costs may be separate3 | Branded and compounded prescription options; availability and eligibility vary3 | Free insurance check and carrier support are described; coverage remains plan-specific3 | Many members may start within a week; not guaranteed3 | 6.6/10 | Current offerNo verified promo codeChecked 2026-07-23 | |||
![]() | Serena Healthaffiliate relationship · commission may apply | GLP-related offers advertised from $192, $199, and $279/month depending on listed formulation1 | Semaglutide + B6 injectable, semaglutide sublingual, and tirzepatide + B6 injectable are listed; medication approval status is not stated1 | Self-pay; HSA/FSA described; no insurance billing stated1 | Shipping described within 24–48 hours after approval; delivery described as 3–5 business days1 | 5.9/10 | Current offerNo verified promo codeChecked 2026-07-23 | ||
![]() | Gala GLP-1affiliate relationship · commission may apply | Compounded GLP-1/GIP advertised from $179/month on a yearly subscription plan4 | Compounded GLP-1/GIP and selected branded options4 | Self-pay; insurance not required4 | Not stated4 | 5.5/10 | Current offerNo verified promo codeChecked 2026-07-23 | ||
![]() | Oak Longevityaffiliate relationship · commission may apply | Program advertised from $119/month; page metadata exposes other figures, so checkout verification is required2 | Semaglutide and tirzepatide options are described2 | Insurance process is not stated clearly enough to treat as coverage support2 | Not stated2 | 5.3/10 | Current offerNo verified promo codeChecked 2026-07-23 |
How we evaluated · why trust this
We compared 4 providers, checked 5 dated sources, and applied 5 published criteria. Scores use the same weighted rubric in the table and every provider card. Commission is excluded from scoring.
Lead generation, not advertising. Free · No commitment · 30 seconds. We do not share contact details unless the person separately requests matching and gives explicit consent.
Read the full scoring methodSource-backed deep cards
Pros, limitations, subscores, and bottom lines come from the same dated evidence that drives the table—not a second hidden ranking.
#1 · Best for Insurance-navigation support and ongoing check-ins
Bottom line
Found stands out here for insurance-navigation support and ongoing check-ins, based on dated commercial evidence—not medical outcomes or individual suitability.3

#2 · Best for Visible review and shipping expectations with explicit product-status uncertainty
Bottom line
Serena Health stands out here for visible review and shipping expectations with explicit product-status uncertainty, based on dated commercial evidence—not medical outcomes or individual suitability.1

#3 · Best for A stated flat monthly figure across dose levels on a yearly plan
Bottom line
Gala GLP-1 stands out here for a stated flat monthly figure across dose levels on a yearly plan, based on dated commercial evidence—not medical outcomes or individual suitability.4

#4 · Best for Readers willing to verify a low headline price directly
Bottom line
Oak Longevity stands out here for readers willing to verify a low headline price directly, based on dated commercial evidence—not medical outcomes or individual suitability.2
Section winners
These are evidence-category leaders, not medical recommendations.
If you want Insurance-navigation support and ongoing check-ins
Found stands out here for insurance-navigation support and ongoing check-ins, based on dated commercial evidence—not medical outcomes or individual suitability.3
Read Found review
If you want Visible review and shipping expectations with explicit product-status uncertainty
Serena Health stands out here for visible review and shipping expectations with explicit product-status uncertainty, based on dated commercial evidence—not medical outcomes or individual suitability.1
Read Serena Health review
If you want A stated flat monthly figure across dose levels on a yearly plan
Gala GLP-1 stands out here for a stated flat monthly figure across dose levels on a yearly plan, based on dated commercial evidence—not medical outcomes or individual suitability.4
Read Gala GLP-1 reviewSource ledger
Reviewed against cited first-party and primary sources · Sources checked 2026-07-23 · How evidence review works